Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain
It is generally believed that a successful Zika virus (ZIKV) vaccine should induce neutralizing antibodies against the ZIKV envelope (E) protein to efficiently halt viral infection. However, E-specific neutralizing antibodies have been implicated in a phenomenon called antibody-dependent enhancement...
Enregistré dans:
Auteurs principaux: | Loulieta Nazerai, Søren Buus, Anette Stryhn, Allan Randrup Thomsen, Jan Pravsgaard Christensen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f35c58cfd4ae4020b4a0433eafa35e0c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
par: Mark J. Bailey, et autres
Publié: (2019) -
NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus
par: Samuel Santos Pereira, et autres
Publié: (2021) -
Zika Virus NS2A-Mediated Virion Assembly
par: Xianwen Zhang, et autres
Publié: (2019) -
First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients
par: Zahra Hasanshahi, et autres
Publié: (2021) -
Reovirus Nonstructural Protein σNS Recruits Viral RNA to Replication Organelles
par: Christopher H. Lee, et autres
Publié: (2021)